Antria Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Antria General Information

Description

Operator of a clinical research organization intended to specialize in the development of innovative cellular therapies. The company focuses on the discovery and development of new products and treatments with stem cells derived from adult patients' fat cells, known as autologous-derived stem cells, enabling doctors to help patients with various chronic and acute medical conditions.

Contact Information

Website
www.antria.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Indian Springs Road
  • Suite 202
  • Indiana, PA 15701
  • United States
+1 (724)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 300 Indian Springs Road
  • Suite 202
  • Indiana, PA 15701
  • United States
+1 (724)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antria Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
2. Later Stage VC 30-Jul-2015 Cancelled Generating Revenue
1. Seed Round 24-Jan-2013 $1.44M $1.44M Completed Generating Revenue
To view Antria’s complete valuation and funding history, request access »

Antria Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Antria Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160130557-A1 Formulations containing and kit for using adipose-derived stem cells and use thereof Inactive 07-Dec-2012
US-20140162355-A1 Formulations containing and kit for using adipose-derived stem cells and use thereof Inactive 07-Dec-2012
US-20160228607-A1 Clinical applications of formulations containing adipose-derived stem cells Active 07-Dec-2012
US-9956317-B2 Clinical applications of formulations containing adipose-derived stem cells Active 07-Dec-2012 C12N5/0667

Antria Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Central and Northern Pennsylvania Accelerator/Incubator Minority
To view Antria’s complete investors history, request access »

Ready to get started?

Request a free trial

Antria FAQs

  • When was Antria founded?

    Antria was founded in 2011.

  • Where is Antria headquartered?

    Antria is headquartered in Indiana, PA.

  • What industry is Antria in?

    Antria’s primary industry is Drug Discovery.

  • Is Antria a private or public company?

    Antria is a Private company.

  • What is Antria’s current revenue?

    The current revenue for Antria is .

  • How much funding has Antria raised over time?

    Antria has raised $1.44M.

  • Who are Antria’s investors?

    Ben Franklin Technology Partners of Central and Northern Pennsylvania has invested in Antria.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »